"Bloodstream Infections Among Patients Treated with Intravenous Epoprostenol or Intravenous Treprostinil for Pulmonary Arterial Hypertension" – March 2, 2007. Reported by.

"The Role of Anti-Endothelial Cell Antibody-Mediated Microvascular Injury in the Evolution of Pulmonary Fibrosis in the Setting of Collagen Vascular Disease," by Cynthia M. Magro, M.D.¹; Clay B. Marsh, M.D.²; James N. Allen, M.D.²; Patrick Ross, M.D.³; David Liff, M.D.⁴; Deborah A. Knight, MS.c.⁵; W. James Waldman, Ph.D.⁵; Tibor Nadasdy, M.D.⁵; Daniel J. Cowden, M.D.^,5 March 1, 2007.

"Scleroderma, Systemic Lupus Erythematosus, and Pulmonary Arterial Hypertension," by Joseph Shanahan, M.D., January 25, 2007

Cyclophosphamide versus Placebo in Scleroderma Lung Disease (June 2006) – Posted June 30, 2006

by Donald P. Tashkin, M.D., Robert Elashoff, Ph.D., Philip J. Clements, M.D., M.P.H., Jonathan Goldin, M.D., Ph.D., Michael D. Roth, M.D., Daniel E. Furst, M.D., Edgar Arriola, Pharm.D., Richard Silver, M.D., Charlie Strange, M.D., Marcy Bolster, M.D., James R. Seibold, M.D., David J. Riley, M.D., Vivien M. Hsu, M.D., John Varga, M.D., Dean E. Schraufnagel, M.D., Arthur Theodore, M.D., Robert Simms, M.D., Robert Wise, M.D., Fredrick Wigley, M.D., Barbara White, M.D., Virginia Steen, M.D., Charles Read, M.D., Maureen Mayes, M.D., Ed Parsley, D.O., Kamal Mubarak, M.D., M. Kari Connolly, M.D., Jeffrey Golden, M.D., Mitchell Olman, M.D., Barri Fessler, M.D., Naomi Rothfield, M.D., Mark Metersky, M.D., for the Scleroderma Lung Study Research Group

Dynamics of Disease – "Bronchiolar Airway Disorders and Bronchiolitis Obliterans" – Posted April 3, 2006
by Gary R. Epler, M.D.

Shortcut to Connective Tissue Bronchiolitis Obliterans: /www.epler.com/boo4.html

"Medical Therapy For Pulmonary Arterial Hypertension"

ACCP Evidence-Based Clinical Practice Guidelines (March, 2006)

David B. Badesch, M.D., FCCP; Steve H. Abman, M.D.; Gregory S. Ahearn, M.D.; Robyn J. Barst, M.D.; Douglas C. McCrory, M.D., MHSc; Gerald Simonneau, M.D.; and Vallerie V. McLaughlin, M.D., FCCP

www.chestjournal.org/cgi/reprint/126/1_suppl/35S.pdf (PDF Version)

Online version: www.chestjournal.org/cgi/content/full/126/1_suppl/35S

A Randomized Trial of Inhaled Cyclosporine in Lung-Transplant Recipients (2006)

by: Aldo T. Iacono, M.D.; Bruce A. Johnson, M.D.; Wayne F. Grgurich, B.S.; J. Georges Youssef, M.D.; Timothy E. Corcoran, Ph.D.; Deidre A. Seiler, M.S.N.; James H. Dauber, M.D.; Gerald C. Smaldone, M.D., Ph.D.; Adriana Zeevi, Ph.D.; Samuel A. Yousem, M.D.; John J. Fung, M.D., Ph.D.; Gilbert J. Burckart, Pharm.D.; Kenneth R. McCurry, M.D.; and Bartley P. Griffith, M.D.

"Sitaxsentan (Thelin™) Becomes the First Agent to Show Efficacy Against PAH-CTD" (2006)"
Used with permission from Pinpoint Limited, "Cardiology News, " December/January 2006 issue.

(You need Adobe Acrobat Reader to open this file. If you don't have Acrobat Reader, download it FREE.)

"Pulmonary Hypertension in Interstitial Lung Disease" (2005) posted 3/27/2006
by Charlie Strange; Kristin B. Highland
Charlie Strange and Kristin B. Highland, Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA

"Chronic Cough in Adults With Interstitial Lung Disease" (2005)
by J Mark Madison; Richard S Irwin, Division of Pulmonary, Allergy and Critical Care Medicine, University of Massachusetts Medical School, Worcester, Mass.

"New Developments in Scleroderma Interstitial Lung Disease" (2005)
by Kristin B. Highland^a; Richard M. Silver^b

^aAssistant Professor of Medicine, Division of Pulmonary, Critical Care, Allergy and Clinical Immunology

^bProfessor of Medicine and Pediatrics, Director, Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, S.C.

"Sitaxsentan Broadens Treatment Options for Pulmonary Arterial Hypertension" (2005)
by Paula Moyer, M.A.

"Changing the Prognosis of Pulmonary Arterial Hypertension: Impact of Medical Therapy" (2005)
by Murali M Chakinala, M.D.

"Lung Transplantation and Interstitial Lung Disease" (2005)
by Raed Alalawi,^a Timothy Whelan,^b Ravinder S Bajwa,^a Tony N Hodges,^{a a}Division of Pulmonary and Critical Care Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, and ^bDivision of Pulmonary, Allergy and Critical Care, University of Minnesota, Minneapolis, Minnesota, USA

Pulmonary Arterial Hypertension Expert Column
"Scleroderma and Pulmonary Arterial Hypertension" (2005)
by Fredrick Wigley, M.D., Professor, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; Shikha Nanda, M.D., Bsc (Hon), Clinical Fellow, Department of Rheumatology, Johns Hopkins Hospital, Baltimore, Maryland

"Inside Scleroderma: A Focus on Cardiopulmonary Complications of Systemic Sclerosis" (2004) Posted June 9, 2006
San Antonio, Texas

"Pulmonary Vascular Disease" (2004) Posted March 15, 2006
CHEST 2004: 70th Annual Meeting of the American College of Chest Physicians

"Scleroderma and Interstitial Lung Disease: An Expert Interview With Art Theodore, M.D." (2004)

"Pleural Effusion in Interstitial Lung Disease" (2004)
by Kristin B. Highland and John E. Heffner, Division of Pulmonary Critical Care Medicine and Allergy, Medical University of South Carolina, Charleston, South Carolina, USA

"Scleroderma – Pathogenesis and Treatment" (collection of abstracts by various authors) (2004)
Long-term Evaluation of Lung Function in Patients Affected by Scleroderma Treated With Cyclic Iloprost Infusions. Caramaschi P, Biasi D, Ferrari M, et al, Rheumatol Int.

"Sitaxsentan May Ease Effects of Pulmonary Hypertension in Patients With Connective Tissue Disease" (2004)
by Jane Salodof MacNeil, freelance writer for "Medscape," Reviewed by Gary D. Vogin, M.D.

Pulmonary Arterial Hypertension Expert Column: "Scleroderma and Interstitial Lung Disease: An Expert Interview With Art Theodore, M.D." (2004)
Art Theodore, M.D. is Director of the Medical Intensive Care Unit at Boston Medical Center (Boston, Massachusetts) and Principal Investigator for the Boston University site of the Scleroderma Lung Study (SLS). He is also the Co-Principal Investigator for the Boston University site of the Bosentan Use in Interstitial Lung Disease (BUILD - 2) trial.

"Ask the Experts: Lung Transplantation in Patient With Scleroderma" (2004)
Response from Steven D. Nathan, M.D., Medical Director, Lung Transplant Program, Inova Fairfax Hospital, Falls Church, Virginia

"Advances in the Treatment of Rheumatic Interstitial Lung Disease" (2004)
by Robert Vassallo and Charles F. Thomas, Thoracic Diseases Research Unit, Division of Pulmonary Critical Care, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota

Age and Risk of Pulmonary Arterial Hypertension in Scleroderma (2003)
by Lionel Schachna, MBBS, FRACP, Ph.D.; Fredrick M. Wigley, M.D.; Betty Chang, M.D., CM, Ph.D.; Barbara White, M.D.; Robert A. Wise, M.D., FCCP and Allan C. Gelber, M.D., MPH, Ph.D. From the Divisions of Rheumatology (Drs. Schachna, Wigley, and Gelber) and Pulmonary and Critical Care Medicine (Drs. Chang and Wise), Johns Hopkins University School of Medicine; and Division of Rheumatology, University of Maryland School of Medicine (Dr. White), Baltimore, Maryland.

"Elevated Levels of Leukotriene B4 and Leukotriene E4 in Bronchoalveolar Lavage Fluid From Patients With Scleroderma Lung Disease" (2003)
by Kowal-Bielecka O, Distler O, Kowal K, et al.Arthritis and Rheumatism. 2003;48(6):1639-1646

"Evaluation and Management of Pulmonary Hypertension in Systemic Sclerosis" (2003)
by Ioana R. Preston and Nicholas S. Hill, Division of Pulmonary, Critical Care and Sleep Medicine, Tufts-New England Medical Center and Tufts School of Medicine, Boston, Massachusetts, USA

"The Assessment of Anti-Endothelial Cell Antibodies in Scleroderma-Associated Pulmonary Fibrosis" – A Study of Indirect Immunofluorescent and Western Blot Analysis in 49 Patients With Scleroderma (2003)
Raghav Wusirika, M.D.,¹ Clodoveo Ferri, M.D.,² Mary Marin,³ Deborah A. Knight, M.S.,³ W. James Waldman, Ph.D.,³ Patrick Ross, Jr., M.D., Ph.D.,⁴ and Cynthia M. Magro, M.D.³

¹College of Medicine and Public Health, ³Department of Pathology, and ⁴Department of Thoracic and Cardiovascular Surgery, the Ohio State University, Columbus; and ²Rheumatology Unit, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy

"Direct and Indirect Immunofluorescence as a Diagnostic Adjunct in the Interpretation of Nonneoplastic Medical Lung Disease" (2003)
Cynthia M. Magro, M.D.,¹ Carl Morrison, M.D.,¹ Amy Pope-Harman, M.D.,² Susan K. Rothrauff, MPAS, PA-C,³ and Patrick Ross, Jr., M.D., Ph.D.³

¹Department of Pathology, ²Division of Pulmonary and Critical Care Medicine, and ³Division of Cardiothoracic Surgery, the Ohio State University Medical Center, Columbus, Ohio

"Editorial Review: Pulmonary Hypertension in Systemic Sclerosis: Bete Noire No More?" from "Current Opinion in Rheumatology" (2002)
by John Varga, M.D.

"Interstitial Lung Disease: Pathophysiology and Genetic Predisposition" (2000) from Medscape General Medicine™
by Penelope A. Lympany, Ph.D., and Roland M. du Bois, M.D., Imperial College of Science, Technology and Medicine, London, UK

Ask the Experts: "Diagnosis of Sarcoidosis With an Increased ACE Level and a Normal Chest X-Ray?" (Not specifically about scleroderma, but mentions it in reference to elevated ACE level) (2000)
Response from John J. Cush, M.D., Clinical Professor of Internal Medicine, University of Texas Southwestern Medical School at Dallas; Chief, Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas, Texas

"The Lung in Mixed Connective Tissue Disease" (1999)
Carlos E. Girod, M.D., Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; Marvin I. Schwarz, M.D., Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado

"Scleroderma Lung Disease: A Common Phenomenon in a Rare Disease" (1998)
Publication: Drugs and Therapy Perspectives (Drug Ther Perspect 11(10):9-11, 1998)

Lymphocytic Bronchitis/Bronchiolitis in a Patient with Primary Biliary Cirrhosis (1995) – Posted April 3, 2006

By G. Chatté*, N. Streichenberger**, O. Boillot+, D. Gille+, R. Loire**, J-F. Cordier*
Depts of *Pulmonary Medicine and **Pathology, Hôpital Cardiovasculaire et Pneumologique Louis Pradel, Université Claude Bernard, Lyon, France. +Liver Transplantation Unit, Hôpital Edouard Herriott, Lyon, France.